The Socioeconomic Burden of Coronary Heart Disease in Korea.
- Author:
Hoo Sun CHANG
1
;
Han Joong KIM
;
Chung Mo NAM
;
Seung Ji LIM
;
Young Hwa JANG
;
Sera KIM
;
Hye Young KANG
Author Information
1. Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Angina;
Coronary disease;
Cost of illness;
Insurance claim;
Myocardial infarction
- MeSH:
Adult;
Age Factors;
Aged;
Aged, 80 and over;
Angina Pectoris/economics/epidemiology;
Coronary Disease/*economics/epidemiology;
*Cost of Illness;
Female;
Health Care Costs/statistics & numerical data;
Humans;
Insurance, Health/statistics & numerical data;
Male;
Middle Aged;
Myocardial Infarction/economics/epidemiology;
Prevalence;
Republic of Korea/epidemiology;
Sex Factors;
Socioeconomic Factors;
Young Adult
- From:Journal of Preventive Medicine and Public Health
2012;45(5):291-300
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVES: We aimed to estimate the annual socioeconomic burden of coronary heart disease (CHD) in Korea in 2005, using the National Health Insurance (NHI) claims data. METHODS: A prevalence-based, top-down, cost-of-treatment method was used to assess the direct and indirect costs of CHD (International Classification of Diseases, 10th revision codes of I20-I25), angina pectoris (I20), and myocardial infarction (MI, I21-I23) from a societal perspective. RESULTS: Estimated national spending on CHD in 2005 was 2.52 billion dollar . The majority of the spending was attributable to medical costs (53.3%), followed by productivity loss due to morbidity and premature death (33.6%), transportation (8.1%), and informal caregiver costs (4.9%). While medical cost was the predominant cost attribute in treating angina (74.3% of the total cost), premature death was the largest cost attribute for patients with MI (66.9%). Annual per-capita cost of treating MI, excluding premature death cost, was 3183 dollar, which is about 2 times higher than the cost for angina (1556 dollar). CONCLUSIONS: The total insurance-covered medical cost (1.13 billion dollar) of CHD accounted for approximately 6.02% of the total annual NHI expenditure. These findings suggest that the current burden of CHD on society is tremendous and that more effective prevention strategies are required in Korea.
